Table 3.
Patient characteristics (n=1318)
|
Age (years), median (IQR) |
53.2 (44.7; 62.3) |
|
|---|---|---|
| Tinnitus duration (years), median (IQR) | 5.2 (1.6; 12.2) | |
|
Sex (N, %) |
|
|
| Male |
844 |
(64.0%) |
| Female |
474 |
(36.0%) |
|
Country (language) (N,%) |
|
|
| Germany (German) |
1149 |
(87.2%) |
| Belgium (Dutch) |
38 |
(2.9%) |
| Brazil (Portuguese) |
98 |
(7.4%) |
| Argentina (Spanish) |
33 |
(2.5%) |
|
Laterality (N, %*) |
|
|
| Right |
391 |
(29.7%) |
| Left |
504 |
(38.2%) |
| Both sides/inner head |
401 |
(30.4%) |
|
Tinnitus severity at baseline on the basis of the THI (N, %*) |
|
|
| Slight |
129 |
(9.8%) |
| Mild |
344 |
(26.1%) |
| Moderate |
361 |
(27.4%) |
| Severe |
307 |
(23.3%) |
| Catastrophic |
151 |
(11.5%) |
|
Etiology (N, %**) |
|
|
| Noise trauma |
238 |
(18.1%) |
| Injury of cervical spine |
174 |
(13.2%) |
| Change of hearing |
327 |
(24.8%) |
| Stress |
565 |
(42.9%) |
| Head injury |
155 |
(11.8%) |
| Other |
573 |
(43.4%) |
|
Type of treatment (N, %) |
|
|
| Pharmacological treatment |
237 |
(18.0%) |
| Transcranial direct current stimulation |
33 |
(2.5%) |
| Transcutaneous vagus nerve stimulation |
24 |
(1.8%) |
| Repetitive transcranial magnetic stimulation |
260 |
(19.7%) |
| Other |
37 |
(2.8%) |
| None (only baseline) | 727 | (55.2%) |
IQR: interquartile range,
* do not add up to 100% or n=1318 due to occasional missing values.
** do not add up to 100% or n=1318 due to multiple answers.